Celcuity Inc. (CELC): Price and Financial Metrics
CELC Price/Volume Stats
| Current price | $13.19 | 52-week high | $22.19 |
| Prev. close | $12.73 | 52-week low | $11.51 |
| Day low | $12.50 | Volume | 205,400 |
| Day high | $13.25 | Avg. volume | 279,626 |
| 50-day MA | $14.90 | Dividend yield | N/A |
| 200-day MA | $16.34 | Market Cap | 489.74M |
CELC Stock Price Chart Interactive Chart >
Celcuity Inc. (CELC) Company Bio
Celcuity LLC, a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the response rates of cancer patients treated with targeted therapies in the United States. It develops CELx tests to diagnose breast, lung, colon, ovarian, kidney, bladder, and hematological cancers. The company was founded in 2012 and is based in Minneapolis, Minnesota.
CELC Price Returns
| 1-mo | -16.52% |
| 3-mo | -23.98% |
| 6-mo | N/A |
| 1-year | -4.00% |
| 3-year | -20.06% |
| 5-year | 32.03% |
| YTD | -9.47% |
| 2023 | 4.00% |
| 2022 | 6.22% |
| 2021 | 44.00% |
| 2020 | -13.91% |
| 2019 | -55.65% |
Loading social stream, please wait...